Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Changing Landscape of Journalology in Medicine.

Seminars in nuclear medicine·2019
Same author

Systematic reviews in restorative dentistry: discussing relevant aspects.

Journal of esthetic and restorative dentistry : official publication of the American Academy of Esthetic Dentistry ... [et al.]·2019
Same author

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2019
Same author

Guidance for reporting outcomes in clinical trials: scoping review protocol.

BMJ open·2019
Same author

Systematic reviews in dentistry: Current status, epidemiological and reporting characteristics.

Journal of dentistry·2019
Same author

Screening for depression in women during pregnancy or the first year postpartum and in the general adult population: a protocol for two systematic reviews to update a guideline of the Canadian Task Force on Preventive Health Care.

Systematic reviews·2019
Same journal

Dual-drug-loaded nanohydrogel for intraoperative local application: sequential release-mediated spatiotemporal targeting of diverse secondary injury mechanisms to improve long-term prognosis in traumatic brain injury.

BMC medicine·2026
Same journal

Single-nucleus analysis of menstrual fluid highlights gene expression differences in epithelial cells of endometriosis donors.

BMC medicine·2026
Same journal

Impact of hepatotoxicity and lipid metabolism-related toxicity on survival and quality of life in patients with high-volume metastatic hormone-sensitive prostate cancer treated with rezvilutamide in the CHART trial: a post hoc analysis.

BMC medicine·2026
Same journal

The impact of public health and social measures on social contact patterns and transmission of COVID-19 in Hong Kong.

BMC medicine·2026
Same journal

Leveraging primary care data to understand military veteran health in England: feasibility study and matched-control comparison of recorded conditions.

BMC medicine·2026
Same journal

Focal adhesion kinase FAK interplays with ROR1 in the aggressiveness of chronic lymphocytic leukemia.

BMC medicine·2026
See all related articles

Related Experiment Videos

CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials.

Kenneth F Schulz1, Douglas G Altman, David Moher

  • 1Family Health International, Research Triangle Park, NC 27709, USA. kschulz@fhi.org

BMC Medicine
|March 26, 2010
PubMed
Summary
This summary is machine-generated.

The CONSORT 2010 statement offers updated guidelines for reporting randomized controlled trials. This revision incorporates new evidence to enhance the quality and transparency of clinical trial reporting.

Related Experiment Videos

Area of Science:

  • Clinical Trials Methodology
  • Evidence-Based Medicine
  • Scientific Reporting Standards

Background:

  • Randomized controlled trials (RCTs) are crucial for medical evidence.
  • Consistent and transparent reporting of RCTs is essential for accurate interpretation.
  • The CONSORT (CONsolidated Standards Of Reporting Trials) statement aims to improve RCT reporting.

Framework:

  • The CONSORT 2010 statement provides updated guidelines for reporting clinical trials.
  • It addresses methodological advancements and practical experiences in trial conduct.
  • Key updates focus on enhancing clarity, completeness, and accuracy in reporting.

Implementation:

  • The CONSORT 2010 checklist and flow diagram are key components.
  • Authors are encouraged to adhere to these updated reporting standards.
  • Dissemination efforts ensure widespread adoption by researchers and journals.

Implications:

  • Improved reporting enhances the reliability and interpretability of trial findings.
  • Facilitates better evidence synthesis and meta-analyses.
  • Ultimately strengthens the foundation of evidence-based medical practice.